GLP-1 and incretin research peptides in Canada. Retatrutide, Tirzepatide, Semaglutide, Cagrilintide. Purity and measured content published per lot.
Best sellerPeptides
Triple GIP / GLP-1 / Glucagon Agonist · 10, 20, 40 & 120 mg Retatrutide is a synthetic peptide developed for controlled laboratory research involving multi-receptor signaling systems. It is structurally designed to interact with GLP-1, GIP, and glucagon receptor pathways within experimental environments.
RETA-CA-26F-1099.637%
11.76 mg / 10 mg
$59.95CAD
Best sellerPeptides
Dual GIP / GLP-1 Agonist · 10, 30 & 65 mg Tirzepatide is a synthetic peptide developed for controlled laboratory research involving dual incretin receptor signaling systems. It is structurally designed to interact with GLP-1 and GIP receptor pathways within experimental environments.
TIRZ-CA-26G-1099.634%
11.42 mg / 10 mg
$34.95CAD
Best sellerPeptides
GLP-1 Receptor Agonist · 10 mg Semaglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1), a naturally occurring incretin hormone involved in glucose-dependent signaling. It is developed for controlled laboratory investigation within regulated experimental environments.
10 mgSEMA-CA-26F-1099.504%
11.27 mg / 10 mg
$54.95CAD
Best sellerPeptides
Selective Amylin Agonist (LY3841136) · 10 mg This product is supplied as eloralintide (LY3841136), a long-acting, selective amylin receptor agonist studied in research on metabolic and body-weight regulation.
10 mgELOR-CA-26G-1099.810%
12.42 mg / 10 mg
$144.95CAD
Best sellerPeptides
Long-Acting Amylin Analogue · 5 & 10 mg Cagrilintide is a synthetic peptide developed for controlled laboratory research involving amylin receptor signaling systems. It is structurally designed to interact with amylin-associated pathways within experimental environments.
CAG-CA-26A-0199.446%
5.62 mg / 5 mg
$69.95CAD
Peptides
Nicotinamide N-Methyltransferase (NNMT) Inhibitor Research Compound 5-Amino-1MQ is a small-molecule research compound studied as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular metabolic regulation. It is developed for controlled laboratory investigation within experimental environments.
10 mg51Q-CA-26A-0199.55%
11.17 mg / 10 mg
$44.95CAD
Peptides
Growth Hormone Fragment AOD-9604 is a synthetic peptide corresponding to the C-terminal fragment (176–191) of human growth hormone, studied in research for lipolytic-pathway activity.
5 mgAOD-CA-26I-0599.905%
5.38 mg / 5 mg
Heavy metals · Endotoxin tested
$89.95CAD
Peptides
GLP-1 / Glucagon Dual Agonist · 10 mg Mazdutide is a synthetic peptide studied in research as a dual agonist of the glucagon-like peptide-1 (GLP-1) and glucagon receptors.
10 mg$164.95CAD
Out of stockCapsules
PPARδ Agonist Research Compound SLU-PP-332 is a small-molecule research compound studied as a selective peroxisome proliferator-activated receptor delta (PPARδ) agonist. It is developed for controlled laboratory investigation involving nuclear receptor signaling systems.
666.72 mg / 250 mcg
$29.95CAD
Lot, purity and measured content on every card match the published certificate.
Lyophilized research peptides and blends — BPC-157, TB-500, retatrutide, tirzepatide, ipamorelin, semax — with purity and measured content per lot.
53 products →Metered research sprays of semax, selank, BPC-157, KPV, PT-141 and oxytocin, filled from a tested powder batch.
21 products →Oral-format research compounds pre-measured per capsule, with measured content per lot on the published certificate.
20 products →Khavinson short peptides — epitalon, pinealon, cartalax, vesugen, livagen, crystagen — each matched to one tissue.
20 products →NAD+ and glutathione research vials at 500 mg to 1500 mg, with measured content verified per lot.
2 products →GHK-Cu and AHK-Cu copper peptides for dermal and hair-follicle research, with copper content reported per lot.
2 products →The incretin class covers compounds that act at the GLP-1 receptor and, in the newer molecules, at the GIP and glucagon receptors alongside it. The published research on this group is unusually deep for a research-peptide category: semaglutide and tirzepatide both carry large named clinical programmes, and retatrutide — a triple agonist — has phase 2 data in the literature under its own compound code.
This category groups the single, dual and triple receptor agonists together with the amylin analogues, because the research questions overlap. Cagrilintide and eloralintide are studied at the amylin receptor rather than the incretin receptors, and appear here for that reason. Orforglipron sits in the same collection despite being a non-peptide small molecule, since it is characterised as an orally available GLP-1 receptor agonist.
Every lot in this category is independently assayed before it is released. The batch identifier, the measured purity and the measured content are printed on the product card and on the certificate itself, so the numbers are visible before anything is added to a cart rather than after delivery. All compounds are supplied strictly as laboratory research materials.
In this category: Retatrutide · Tirzepatide · Semaglutide · Cagrilintide
They are supplied here strictly as laboratory research materials, and are sold on that basis. None of the compounds in this category is approved by Health Canada in this form for diagnosis, treatment or prevention of any condition, and nothing on this site describes human use. The approved medicines that share an active ingredient with some of these compounds are separate, prescription-only products from their originator manufacturers.
The number of receptors each one is characterised as acting at. Semaglutide is described in the literature as a single GLP-1 receptor agonist; tirzepatide as a dual agonist at GLP-1 and GIP; retatrutide as a triple agonist adding the glucagon receptor. That difference is structural and is the reason the three are studied against one another rather than interchangeably. The comparison guides linked from this page set out what the published trials report for each.
They are amylin receptor agonists rather than incretin agonists, so mechanistically they sit apart from the GLP-1 group. They are collected here because the research questions overlap — the published work studies them alongside and in combination with incretin compounds rather than in isolation.
The lot code, the HPLC purity figure and the measured content against the labelled amount, plus the issuing laboratory and its test date. All of it is on the product card before anything is added to a cart, and the full certificate is linked from the lot code so the numbers can be read in the laboratory’s own report rather than in our summary of it.
All products are supplied for in vitro and laboratory research purposes only.
